Keyphrases
Survivors
100%
Intensive Care Unit Discharge
100%
Hemostasis
100%
Rotational Thromboelastometry (ROTEM)
100%
Fibrinolysis
100%
COVID-19
100%
Venous Thromboembolism
83%
Fibrinogen
50%
Plasminogen Activator
50%
Age of Onset
33%
6-month Follow-up
33%
Lysis Time
33%
D-dimer
33%
Maximum Clot Firmness
33%
Lysis
33%
Hemostatic Abnormalities
33%
Difference in Medians
16%
Tissue Type
16%
Maastricht
16%
Whole Blood
16%
Intensive Care Unit
16%
Intensive Care
16%
Hypercoagulability
16%
Hospital Discharge
16%
Hemostasis Laboratory
16%
Clot
16%
Tissue Plasminogen Activator (t-PA)
16%
Tissue Factor
16%
Clotting Time
16%
Laboratory Parameters
16%
Viscoelastic Testing
16%
Long-term Morbidity
16%
Hemostasis Parameters
16%
Prothrombotic Phenotype
16%
Parameter Type
16%
Coronavirus Disease (COVID)
16%
INIS
diseases
100%
patients
100%
units
100%
fibrinolysis
100%
coronaviruses
100%
lysis
57%
plasminogen
57%
fibrinogen
42%
tissues
28%
concentration
28%
hemostatics
28%
dimers
28%
laboratories
14%
blood
14%
hospitals
14%
morbidity
14%
phenotype
14%
range
14%
exploration
14%
Medicine and Dentistry
Intensive Care Unit
100%
Fibrinolysis
100%
Blood Stasis
100%
COVID-19
100%
Thromboelastometry
85%
Venous Thromboembolism
71%
Fibrinogen
42%
Plasminogen Activator
42%
Hemostat
28%
D-Dimer
28%
Intensive Care
14%
Tissue Plasminogen Activator
14%
Thromboplastin
14%